Duke University School of Nursing, Durham, North Carolina (Drs Crego, Masese, and Tanabe and Ms Bonnabeau); Social & Scientific Systems, Inc, Durham, North Carolina (Dr Douglas); Duke Office of Clinical Research, Durham, North Carolina (Mr Rains); and Duke University Medicine, Durham, North Carolina (Dr Shah).
Crit Care Nurs Q. 2021;44(2):160-174. doi: 10.1097/CNQ.0000000000000350.
Sickle cell disease (SCD) is a common genetic blood disorder predominantly affecting African Americans in the United States. The objective of this study was to use a multimethods approach to describe how patients with SCD in North Carolina perceive the care they receive in emergency departments (EDs). Fourteen participants completed an interview (n = 10) or 2 focus groups (n = 2 per focus group) and 51 completed surveys. Sixty percent of participants with pain attack "very much" or "quite a bit" avoided going to the ED for care because of prior bad experiences and 50% of participants reported waiting 120 minutes or more in the ED for treatment of their sickle cell pain. Participants reported that stigma associated with provider perception of drug-seeking behavior is a persistent problem in the ED. Participant recommendations warrant further investigation to address persistent SCD quality-of-care concerns in the ED.
镰状细胞病(SCD)是一种常见的遗传性血液疾病,主要影响美国的非裔美国人。本研究的目的是采用多方法学方法描述北卡罗来纳州 SCD 患者如何感知他们在急诊科(ED)接受的护理。14 名参与者完成了访谈(n=10)或 2 个焦点小组(每个焦点小组 n=2),51 名参与者完成了调查。60%的有疼痛发作的参与者“非常”或“相当多”因为之前的糟糕经历而避免去 ED 接受治疗,50%的参与者报告说在 ED 等待 120 分钟或更长时间来治疗他们的镰状细胞疼痛。参与者报告说,与提供者对药物寻求行为的看法相关的污名在 ED 中是一个持续存在的问题。参与者的建议值得进一步调查,以解决 ED 中持续存在的 SCD 护理质量问题。